Today in Drug Research

Drug Research

Biogen to pay $700m to increase stake in Samsung Bioepis Biogen has agreed to increase its stake in biopharmaceutical company Samsung Bioepis to nearly 49.9% in a deal of about $700m with its joint venture (JV) partner Samsung BioLogics. Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

Sorrento acquires lymphatic delivery technology platform from Kimberly-Clark
Sorrento Therapeutics has acquired Kimberly-Clark’s Sofusa lymphatic delivery technology platform for targeted biopharmaceuticals, particularly, the immune checkpoint inhibitors like anti-PD-1, CTLA4, CD47 antibodies and other I-O antibodies.
Drug Research > Drug Delivery > News
Novacap to acquire US-based CDMO PCI Synthesis
Novacap has agreed to acquire Boston-based PCI Synthesis, a pharmaceutical contract development and manufacturing organization (CDMO), for an undisclosed price.
Drug Research > Drug Delivery > News

Drug Discovery & Development

Taiho Pharmaceutical exercises option to develop AB928 in its territories
Arcus Biosciences announced that Taiho Pharmaceutical has exercised its option to obtain an exclusive development and commercialization license to the company’s adenosine receptor antagonist program, which includes AB928 and back-up compounds, in Japan and certain other territories in Asia (excluding China).
Drug Research > Drug Discovery & Development > News
Genmab, Immatics to develop next-generation bispecific cancer immunotherapies
By PBR Staff Writer
Genmab has signed a collaboration and exclusive license agreement with Immatics Biotechnologies to work on next-generation bispecific cancer immunotherapies.
Drug Research > Drug Discovery & Development > News